Company Filing History:
Years Active: 2018-2022
Title: Martin W Skarzynski: Innovator in Cancer Research
Introduction
Martin W Skarzynski is a notable inventor based in North Bethesda, MD, with a focus on cancer research. He holds two patents that contribute significantly to the field of immunology and cancer treatment. His work is characterized by innovative approaches to targeting cancer cells.
Latest Patents
Skarzynski's latest patents include an anti-C3d antibody or antibody fragment, which targets cell surface deposited complement protein C3d. This invention outlines methods for using the antibody to kill cancer cells, along with related methods and compositions. The dual focus on both the antibody and its application in cancer treatment showcases his commitment to advancing medical science.
Career Highlights
Throughout his career, Martin W Skarzynski has worked with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Virginia. His experience in these institutions has allowed him to contribute to significant advancements in health and medicine.
Collaborations
Skarzynski has collaborated with esteemed colleagues, including Adrian U Wiestner and Margaret A Lindorfer. These partnerships have fostered a collaborative environment that enhances research and innovation in cancer therapies.
Conclusion
Martin W Skarzynski's contributions to cancer research through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for new treatments and advancements in medical science.